Medtech

What Is Medtech?

Medical device law defines the medtech industry. A product that diagnoses or treats disease through physical or software means, from a tongue depressor to an MRI scanner, falls under that law, and the companies that make these products form the industry.

Device law splits the industry into two regulatory groups. Medical devices range from single-use instruments to surgical robots, while in-vitro diagnostics cover laboratory and point-of-care tests run on blood or tissue samples. Software that qualifies as a medical device sits inside one of these two groups, and some new products are software only.

The US and Europe dominate the market. According to MedTech Europe, Europe holds 25.6% of the world medtech market, second only to the US, and the European market was worth about €173 billion in 2025.

Why Does the Medtech Industry Matter to Economies and Patients?

• It is a large, well-paid employer. The European industry directly employs more than 950,000 people across over 36,000 companies, per MedTech Europe. In the US, an AdvaMed fact sheet credits medtech with nearly three million direct and indirect jobs, at an average salary of $97,000.

• It sets the pace of change in clinical practice. New procedures often arrive with a new device, such as transcatheter heart valves that replaced open surgery for many patients. How quickly devices reach the market shapes how quickly care itself changes.

How Is the Medtech Industry Structured?

• A handful of large, diversified manufacturers. Companies such as Medtronic, Johnson & Johnson MedTech and Siemens Healthineers sell across many specialties and set the commercial pace in major markets.

• A long tail of small companies. Around 90% of European medtech companies are small and medium-sized enterprises, most with fewer than 50 employees. Many are built around a single product or technology.

• Acquisition as a common exit. Large manufacturers often buy smaller companies once a product has regulatory clearance and early clinical evidence. Startups plan their evidence and financing around that exit.

• Contract manufacturers and suppliers. Specialist firms build finished devices and run sterilization for brand owners, which lets smaller companies sell products without owning factories.

• Regulators and notified bodies. The FDA in the US and notified bodies in the EU review products before market entry. Their capacity and rules shape every company's timeline.

• Trade associations. AdvaMed in the US and MedTech Europe represent the industry on regulation and reimbursement policy.

What Resources Track and Shape the Medtech Industry?

• Regulatory databases. The FDA's 510(k) and MAUDE adverse event databases and the EU's EUDAMED show which devices have been cleared or registered and which adverse events have been reported after launch.

• Industry data. The MedTech Europe Data Hub and AdvaMed's economic reports publish market size and employment figures for their regions.

• International harmonization bodies. The International Medical Device Regulators Forum aligns regulatory approaches across countries, and ISO Technical Committee 210 maintains core device standards such as ISO 13485.

What Are the Key Characteristics of the Medtech Industry?

• Portfolios that span risk classes. A large manufacturer may sell low-risk accessories and high-risk implants side by side, each under its own review route. Running several regulatory tracks at once is a fixed cost of scale in this industry.

• Short product cycles. A new product variant often reaches the market every 1–2 years, according to AdvaMed. Each design change is assessed for regulatory impact, so regulatory work continues long after launch.

• Clinician-driven development. Some devices start with a surgeon or physician who spots a problem in practice. Close collaboration with clinicians continues through testing and training after launch.

• Concentrated buyers. In the US, group purchasing organizations negotiate contracts for many hospitals at once. In Europe, public tenders play a similar role, which puts steady pressure on prices.

What Does the Medtech Industry Contribute?

• Domestic supply. US-made products supply around 70% of the US medtech market, per AdvaMed, which limits the country's exposure to import disruptions.

• Research and patents. The US industry spends more than $20 billion a year on R&D, per AdvaMed, and European medtech patent filings remain at record highs, per MedTech Europe.

• Exports. The US exported $80 billion of medtech in 2024, per AdvaMed.

• Health system productivity. Diagnostics and minimally invasive devices can shorten hospital stays and move care into outpatient settings, which frees capacity across the system.

What Challenges Does the Medtech Industry Face?

• Regulatory cost weighs most on small companies. The EU's Medical Device Regulation raised evidence and documentation requirements for every product. Large manufacturers absorb the cost across big portfolios, while smaller firms carry it product by product. MedTech Europe's 2026 figures record Europe's first-ever fall in medtech company numbers.

• Slowing growth in Europe. European medtech spending grew 1.8% in 2025, against a decade average of around 5.6%, per MedTech Europe. Companies chasing growth in the US take on a second regulatory file and a second evidence program to fund.

• Fragile supply chains. Sterilization capacity and specialist components often come from a few suppliers. In the US, EPA tightened emission limits on ethylene oxide sterilization in 2024, then proposed repealing much of that rule in 2026, which leaves sterilizers planning investment without a settled standard.

• Early-stage funding gaps. Device startups need capital through years of development and review before revenue. Investors fund that gap selectively, so some promising products stall before reaching patients.

What Is the Difference Between Medtech and Healthtech?